Jib. Alak et al., EFFECT OF LACTOBACILLUS-REUTERI ON INTESTINAL RESISTANCE TO CRYPTOSPORIDIUM-PARVUM INFECTION IN A MURINE MODEL OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The Journal of infectious diseases, 175(1), 1997, pp. 218-221
Efficacy of Lactobacillus reuteri as a probiotic for the control of Cr
yptosporidium parvum infection was evaluated in C57BL/6 female mice th
at were immunosuppressed by intraperitoneal inoculation with the LP-BM
5 leukemia virus. Four months after inoculation, mice developed lympha
denopathy, splenomegaly, and susceptibility to C. parvum infection. Af
ter daily prefeeding with L. reuteri (10(8) cfu/day) for 10 days, mice
were challenged with 6.5 X 10(6) C. parvum oocysts and fed L. reuteri
during the entire study. Mice supplemented with L. reuteri and challe
nged with C. parvum cleared parasite loads from the gut epithelium. Ho
wever, unsupplemented animals developed persistent cryptosporidiosis a
nd shed high levels of oocysts in the feces. L. reuteri feeding increa
sed its colonization of the intestinal tract, which was inversely rela
ted to the fecal shedding of oocysts. These findings suggest that L. r
euteri may help prevent C. parvum infection in immunodeficient subject
s.